A large study provides causal evidence of the opposing effects of plasma low-density lipoprotein (LDL) levels on ischemic and hemorrhagic stroke in a Chinese population and suggests there is a a net benefit associated with LDL lowering.
References
Feigin, V. L. et al. N. Engl. J. Med. 379, 2429–2437 (2018).
Sun, L et al. Nat. Med. https://doi.org/10.1038/s41591-019-0366-x (2019).
Di Angelantonio, E. et al. JAMA 302, 1993–2000 (2009).
Fulcher, J. et al. Lancet 385, 1397–1405 (2015).
Karatasakis, A. et al. J. Am. Heart Assoc. 6, e006910 (2017).
Hindy, G. et al. Stroke 49, 820–827 (2018).
Wang, X., Dong, Y., Qi, X., Huang, C. & Hou, L. Stroke 44, 1833–1839 (2013).
Baigent, C. et al. Lancet 376, 1670–1681 (2010).
Amarenco, P. et al. N. Engl. J. Med. 355, 549–559 (2006).
Elkind, M. S. et al. Cerebrovasc. Dis. 28, 266–275 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.S.V.E. discloses receiving personal compensation for serving as an expert witness for Merck/Organon and Auxilium; honoraria for writing chapters on stroke for UpToDate; and research support but no personal compensation for a federally funded clinical trial related to stroke prevention from both the BMS-Pfizer Alliance for Eliquis and Roche; and serving as an unpaid national board member of the American Heart Association. N.S.P. has no competing interests.
Rights and permissions
About this article
Cite this article
Parikh, N.S., Elkind, M.S.V. Divergent effects of lipids on stroke. Nat Med 25, 543–544 (2019). https://doi.org/10.1038/s41591-019-0413-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-019-0413-7
- Springer Nature America, Inc.